LifeStance Health (LFST) Liabilities and Shareholders Equity (2020 - 2026)

LifeStance Health (LFST) has 7 years of Liabilities and Shareholders Equity data on file, last reported at $2.1 billion in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 1.96% year-over-year to $2.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 billion (up 2.31% YoY) and the FY2025 annual result came in at $2.2 billion, up 4.04% from the prior year.
• Liabilities and Shareholders Equity slipped to $2.1 billion in Q1 2026 per LFST's latest filing, from $2.2 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $2.2 billion in Q4 2025 and bottomed at $2.0 billion in Q1 2022.
• The 5-year median for Liabilities and Shareholders Equity is $2.1 billion (2024), against an average of $2.1 billion.
• The widest annual swing landed in 2022, when Liabilities and Shareholders Equity increased 12.8%; it then slipped 3.09% in 2024.
• Tracing LFST's Liabilities and Shareholders Equity over 5 years: stood at $2.2 billion in 2022, then decreased by 2.94% to $2.1 billion in 2023, then rose by 0.39% to $2.1 billion in 2024, then climbed by 4.04% to $2.2 billion in 2025, then retreated by 2.63% to $2.1 billion in 2026.
• Per Business Quant, the three latest LFST Liabilities and Shareholders Equity figures stand at $2.1 billion (Q1 2026), $2.2 billion (Q4 2025), and $2.1 billion (Q3 2025).

Peer Comparison